AngioPhase is an angiogenesis kit which is designed for the analysis of all known phases of the angiogenic process in a convenient and flexible format.
Angiogenesis is a multistep process in which new blood vessels develop from pre-existing vasculature and helps in the natural process of healing and reproduction.
It also plays a key role in many pathological processes including cancer, skin diseases, age-related blindness, diabetic ulcers, cardiovascular disease, and stroke.
AngioPhase utilzes a patented technology, developed by TCS Cellworks, in which human endothelial cells are co-cultured with other human cells in a specially designed medium.
MBL been awarded a license to manufacture and sell the assay in North and South America, as per the non-exclusive agreement with TCS Cellworks.
MBL International CEO Dennis Walczewski said this technology provides many benefits to researchers in the biotechnology and pharmaceutical industries by offering a ready-to-use angiogenesis kit in which test compounds can be added at any time.
"Moreover, both angiogenic simulators and inhibitors can be assessed as well as tubule formation," Walczewski said.
